- Home
- MKZR vs ALBT Comparison
MKZR vs ALBT Comparison
Compare MKZR & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKZR
- ALBT
- Stock Information
- Founded
- MKZR 2012
- ALBT 2014
- Country
- MKZR United States
- ALBT United States
- Employees
- MKZR N/A
- ALBT N/A
- Industry
- MKZR
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MKZR
- ALBT Health Care
- Exchange
- MKZR Nasdaq
- ALBT Nasdaq
- Market Cap
- MKZR 10.3M
- ALBT 8.4M
- IPO Year
- MKZR N/A
- ALBT N/A
- Fundamental
- Price
- MKZR $5.14
- ALBT $2.09
- Analyst Decision
- MKZR
- ALBT
- Analyst Count
- MKZR 0
- ALBT 0
- Target Price
- MKZR N/A
- ALBT N/A
- AVG Volume (30 Days)
- MKZR 32.8K
- ALBT 43.7K
- Earning Date
- MKZR 11-11-2025
- ALBT 11-13-2025
- Dividend Yield
- MKZR 19.45%
- ALBT N/A
- EPS Growth
- MKZR N/A
- ALBT N/A
- EPS
- MKZR N/A
- ALBT N/A
- Revenue
- MKZR $21,294,932.00
- ALBT $1,159,091.00
- Revenue This Year
- MKZR N/A
- ALBT N/A
- Revenue Next Year
- MKZR N/A
- ALBT N/A
- P/E Ratio
- MKZR N/A
- ALBT N/A
- Revenue Growth
- MKZR 21.25
- ALBT N/A
- 52 Week Low
- MKZR $3.89
- ALBT $1.87
- 52 Week High
- MKZR $55.00
- ALBT $11.66
- Technical
- Relative Strength Index (RSI)
- MKZR 47.64
- ALBT 33.62
- Support Level
- MKZR $4.84
- ALBT $2.13
- Resistance Level
- MKZR $5.63
- ALBT $2.24
- Average True Range (ATR)
- MKZR 0.41
- ALBT 0.11
- MACD
- MKZR -0.04
- ALBT -0.01
- Stochastic Oscillator
- MKZR 35.16
- ALBT 7.67
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.